Ocumetics Technology Corp.

OTC: OTCFF · Healthcare · Medical - Instruments & Supplies

Canadian filerHQ Calgary, ABReports USD

#1143 of 1,394 Healthcare companies by revenue

EA Score

——

FH 14DQ —GM —SS 25

v0.1 · 35/100 weight · pillars only

↑ disclosure history, market scale · ↓ Piotroski F, workforce scale

Methodology →

Revenue TTM

Rev growth YoY (TTM)

needs 8 qtrs

Net income (FY)

-$3.8M

Employees

Market cap

$24.8M

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$00 CAD2025

Net income-$3.8M-5.4M CAD2025

Operating income-$3.8M-5.4M CAD2025

Total assets$1.4M1.9M CAD2025

Liabilities$4.3M5.8M CAD2025

Equity-$2.9M-3.9M CAD2025

Revenue trend

FY2018 – FY2025 · USD

FY18

FY19

FY20

FY21

FY22

FY23

FY24

FY25

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

Ocumetics Technology Corp. booked $0 in FY2025 revenue — among the slowest-growing Healthcare companies we track, at a -Infinity% net margin.

Peers · Healthcare

HeartBeam, Inc.——Skye Bioscience, Inc.——Cytosorbents Corporation55C PetVivo Holdings, Inc.38D

Key facts

CEODean E. Burns

SectorHealthcare

IndustryMedical - Instruments & Supplies

HeadquartersCalgary, AB

ExchangeOTC: OTCFF

Employees3

IPO date2021-11-01

Latest filings

No filings loaded — no CIK (non-SEC filer).

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.